Kiwi
I am somewhat familiar with Boston Scientific, but what I have read there might be a regulatory problem...I just used a technical entry point, but you have a great profit from $40, so you might consider taking a partial profit...I was impressed with the comeback into late trading, but resistance at $320 is very visible to me...M&A is certainly increasing with the biotech group pretty cheap and Big Pharma having patents expiring, so they'll need to acquire. As I mentioned, part of my interest is personal and this seems something that my vascular surgeon might consider...I see him in several months & have let his group of PA's know that I want him to be informed and that I'm interested.
FYI: I was in the financial industry for more than 35 years with more than 22 years with Morgan Stanley. also Merrill & PaineWebber....I retired when I was 60 years old, so that's a long time ago, I'm now 79....you seem sharp and more informed than I am, so I hope you keep feeding info to me...I really like Dew Dilifence's board (Roy Friedman on Twitter), but he is so much more knowledgeable than I am that I just try to pick up ideas from him (RVNC & ENTA for example)
News 
Market Data 
Discover 
AI
